| Q47101799 | Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma |
| Q34867993 | Biology of infantile hemangioma |
| Q88801642 | Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants |
| Q86531929 | Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas |
| Q35942904 | Efficacy of low-dose (90)Sr-(90)Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas |
| Q40773699 | Expression of Cathepsins B, D, and G in Infantile Hemangioma |
| Q64102932 | Expression of Cathepsins B, D, and G in WHO Grade I Meningioma |
| Q91866328 | Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study |
| Q34034894 | Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. |
| Q36159232 | Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation |
| Q37113625 | Masterly inactivity in infantile haemangioma: Does it still hold relevance? |
| Q64970167 | Medical Management of Vascular Anomalies. |
| Q45803788 | Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China |
| Q92066046 | Proliferating Infantile Hemangioma Tissues and Primary Cell Lines Express Markers Associated with Endothelial-to-Mesenchymal Transition |
| Q43662652 | Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis |
| Q27005682 | Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy |
| Q35996249 | Successful and safe treatment of hemangioma with oral propranolol in a single institution |
| Q34209504 | The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies |
| Q35358798 | The use of propranolol in the management of periocular capillary haemangioma--a systematic review |
| Q36761471 | Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma |
| Q92802002 | Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System |
| Q53008897 | Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. |
| Q37657969 | When to stop propranolol for infantile hemangioma |